Cargando…
Microtubule Destabilizing Sulfonamides as an Alternative to Taxane-Based Chemotherapy
Pan-Gyn cancers entail 1 in 5 cancer cases worldwide, breast cancer being the most commonly diagnosed and responsible for most cancer deaths in women. The high incidence and mortality of these malignancies, together with the handicaps of taxanes—first-line treatments—turn the development of alternat...
Autores principales: | González, Myriam, Ovejero-Sánchez, María, Vicente-Blázquez, Alba, Álvarez, Raquel, Herrero, Ana B., Medarde, Manuel, González-Sarmiento, Rogelio, Peláez, Rafael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7918738/ https://www.ncbi.nlm.nih.gov/pubmed/33673002 http://dx.doi.org/10.3390/ijms22041907 |
Ejemplares similares
-
Panobinostat Synergistically Enhances the Cytotoxicity of Microtubule Destabilizing Drugs in Ovarian Cancer Cells
por: Ovejero-Sánchez, María, et al.
Publicado: (2022) -
Methoxy and bromo scans on N-(5-methoxyphenyl) methoxybenzenesulphonamides reveal potent cytotoxic compounds, especially against the human breast adenocarcinoma MCF7 cell line
por: González, Myriam, et al.
Publicado: (2021) -
New indolesulfonamide derivatives targeting the colchicine site of tubulin: synthesis, anti-tumour activity, structure–activity relationships, and molecular modelling
por: Vicente-Blázquez, Alba, et al.
Publicado: (2021) -
New diarylsulfonamide inhibitors of Leishmania infantum amastigotes
por: González, Myriam, et al.
Publicado: (2021) -
The Masked Polar Group Incorporation (MPGI) Strategy in Drug Design: Effects of Nitrogen Substitutions on Combretastatin and Isocombretastatin Tubulin Inhibitors
por: González, Myriam, et al.
Publicado: (2019)